Treatment of common and plantar warts using salicylic acid patches
Evaluation of Performance and Safety of the Medical Device: Salicylic Acid Wart Patch for the Treatment of Common Warts and Plantar Warts
This study is testing if salicylic acid patches can help people aged 6 and older get rid of common and plantar warts.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 6 Years and up |
| Sex | All |
| Sponsor | Langsteiner sp. z o.o. Industry-sponsored |
| Locations | 1 site (Miechów, Małopolskie) |
| Trial ID | NCT06958237 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of salicylic acid wart patches in treating common and plantar warts, which are benign skin lesions caused by the human papilloma virus. The study aims to recruit participants who have at least one wart, measuring up to 1 cm in diameter, and are at least 6 years old. Participants will apply the patches to the affected area to assess the treatment's efficacy in reducing wart size and alleviating associated discomfort. The trial is conducted at the Dr Kowalska Clinic in Miechów, Małopolskie.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 6 years and older with at least one common or plantar wart up to 1 cm in diameter.
Not a fit: Patients with hypersensitivity to salicylic acid, renal impairment, or existing skin conditions at the application site may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide a non-invasive and effective option for patients suffering from painful and psychologically distressing warts.
How similar studies have performed: Previous studies have shown that salicylic acid is an effective treatment for warts, indicating that this approach is supported by existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * giving consent to participate in the clinical trial (consent of the minor's guardian where applicable); * presence of at least 1 wart (common/plantar) on the body, with a lesion up to 1 cm in diameter; * age, at least 6 years. Exclusion Criteria: * failure to meet at least 1 inclusion criterion; * the patient has a known hypersensitivity to salicylic acid, salicylates or any other component of the patch; * patients with renal impairment (renal failure); * patients with skin conditions (e.g. inflammation, wounds, eczema) at the site of application, * patients concurrently using other topical treatments in the area of the wart, * diabetic patients.
Where this trial is running
Miechów, Małopolskie
- Dr Kowalska Clinic — Miechów, Małopolskie, Poland (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.